ranimustine
This page covers all ranimustine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Phase 3 pipeline (1)
- Cymerin · Oncology
Cymerin works by interfering with DNA replication and transcription, ultimately leading to cell death.
Patent intelligence
- ranimustine patent landscape — aggregated cliff calendar, attackable patents, originator estates